Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases

Pharmacology and Therapeutics

Volumn 157, Issue , 2016, Pages 84-104

  Buendia, Izaskun ^a,b   Michalska, Patrycja ^a,b   Navarro, Elisa ^a,b   Gameiro, Isabel ^a,b   Egea, Javier ^a,b   León, Rafael ^a,b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b INSTITUTO TEÓFILO HERNANDO   (Spain)

Author keywords

Electrophile response elements; Neurodegenerative diseases; Neuroinflammation; Nrf2; Nrf2 inducers; Nuclear factor E2 related factor 2; Oxidative stress; Phase II antioxidant response

Indexed keywords

TRANSCRIPTION FACTOR NRF2;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; GENE EXPRESSION; HUMAN; HUNTINGTON CHOREA; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; SLEEP DISORDER; ANIMAL; DNA RESPONSIVE ELEMENT; GENETICS; INFLAMMATION; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INFLAMMATION; NEURODEGENERATIVE DISEASES; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION;

EID: 84952636599     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2015.11.003     Document Type: Review

References (339)

1. D. Aarsland, K. Andersen, J.P. Larsen, A. Lolk, and P. Kragh-Sorensen Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study Arch Neurol 60 2003 387 392
2. Z.I. Alam, S.E. Daniel, A.J. Lees, D.C. Marsden, P. Jenner, and B. Halliwell A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease J Neurochem 69 1997 1326 1329
3. T. Ali, H. Badshah, T.H. Kim, and M.O. Kim Melatonin attenuates d-galactose-induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NF-K B/JNK signaling pathway in aging mouse model J Pineal Res 58 2015 71 85
4. J.I. Alvarez, R. Cayrol, and A. Prat Disruption of central nervous system barriers in multiple sclerosis Biochim Biophys Acta 1812 2011 252 264
5. J.K. Andersen Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10 Suppl. 2004 S18 S25
6. K. Asayama, H. Yamadera, T. Ito, H. Suzuki, Y. Kudo, and S. Endo Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia J Nippon Med Sch 70 2003 334 341
7. C.S. Atwood, R.C. Scarpa, X. Huang, R.D. Moir, W.D. Jones, D.P. Fairlie, and et al. Characterization of copper interactions with Alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42 J Neurochem 75 2000 1219 1233
8. S. Ayala-Pena Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis Free Radic Biol Med 62 2013 102 110
9. E. Balogun, M. Hoque, P. Gong, E. Killeen, C.J. Green, R. Foresti, and et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element Biochem J 371 2003 887 895
10. S.C. Barber, A. Higginbottom, R.J. Mead, S. Barber, and P.J. Shaw An in vitro screening cascade to identify neuroprotective antioxidants in ALS Free Radic Biol Med 46 2009 1127 1138
11. S.C. Barber, and P.J. Shaw Oxidative stress in ALS: key role in motor neuron injury and therapeutic target Free Radic Biol Med 48 2010 629 641
12. L. Barfod, K. Kemp, M. Hansen, and A. Kharazmi Chalcones from Chinese liquorice inhibit proliferation of T cells and production of cytokines Int Immunopharmacol 2 2002 545 555
13. F.C. Barone, and G.Z. Feuerstein Inflammatory mediators and stroke: new opportunities for novel therapeutics J Cereb Blood Flow Metab 19 1999 819 834
14. R. Barros Silva, N.A. Santos, N.M. Martins, D.A. Ferreira, F. Barbosa Jr., V.C. Oliveira Souza, and et al. Caffeic acid phenethyl ester protects against the dopaminergic neuronal loss induced by 6-hydroxydopamine in rats Neuroscience 233 2013 86 94
15. M.F. Beal Neurochemistry and toxin models in Huntington's disease Curr Opin Neurol 7 1994 542 547
16. M.F. Beal Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease Parkinsonism Relat Disord 15 Suppl. 3 2009 S189 S194
17. A.N. Begum, M.R. Jones, G.P. Lim, T. Morihara, P. Kim, D.D. Heath, and et al. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease J Pharmacol Exp Ther 326 2008 196 208
18. A. Belkacemi, S. Doggui, L. Dao, and C. Ramassamy Challenges associated with curcumin therapy in Alzheimer disease Expert Rev Mol Med 13 2011 e34
19. J. Bennett, J. Basivireddy, A. Kollar, K.E. Biron, P. Reickmann, W.A. Jefferies, and et al. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE J Neuroimmunol 229 2010 180 191
20. G. Benzi, and A. Moretti Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system Free Radic Biol Med 19 1995 77 101
21. D.A. Bloom, and A.K. Jaiswal Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression J Biol Chem 278 2003 44675 44682
22. S. Boddupalli, J.R. Mein, S. Lakkanna, and D.R. James Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins A, C, and E Front Genet 3 2012 7
23. V. Bonifati, P. Rizzu, M.J. van Baren, O. Schaap, G.J. Breedveld, E. Krieger, and et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 299 2003 256 259
24. E. Brouillet, C. Jacquard, N. Bizat, and D. Blum 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease J Neurochem 95 2005 1521 1540
25. S.E. Browne, and M.F. Beal Oxidative damage in Huntington's disease pathogenesis Antioxid Redox Signal 8 2006 2061 2073
26. S.E. Browne, R.J. Ferrante, and M.F. Beal Oxidative stress in Huntington's disease Brain Pathol 9 1999 147 163
27. L.I. Brusco, M. Marquez, and D.P. Cardinali Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's disease Neuro Endocrinol Lett 21 2000 39 42
28. M.M. Buckley, K.L. Goa, A.H. Price, and R.N. Brogden Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia Drugs 37 1989 761 800
29. I. Buendia, E. Parada, E. Navarro, R. Leon, P. Negredo, and J. Egea Subthreshold concentrations of melatonin and galantamine improves pathological AD-hallmarks in hippocampal organotypic cultures Mol Neurobiol 2015 10.1007/s12035-015-9272-5
30. D.A. Butterfield, J. Drake, C. Pocernich, and A. Castegna Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide Trends Mol Med 7 2001 548 554
31. I. Caesar, M. Jonson, K.P. Nilsson, S. Thor, and P. Hammarstrom Curcumin promotes A-beta fibrillation and reduces neurotoxicity in transgenic Drosophila PLoS One 7 2012 e31424
32. S. Calne, B. Schoenberg, W. Martin, R.J. Uitti, P. Spencer, and D.B. Calne Familial Parkinson's disease: possible role of environmental factors Can J Neurol Sci 14 1987 303 305
33. D.P. Cardinali, D.E. Vigo, N. Olivar, M.F. Vidal, A.M. Furio, and L.I. Brusco Therapeutic application of melatonin in mild cognitive impairment Am J Neurodegener Dis 1 2012 280 291
34. D. Carnevale, R. De Simone, and L. Minghetti Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems CNS Neurol Disord Drug Targets 6 2007 388 397
35. R.N. Chakravarti, and D. Chakravarti Andrographolide, the active constituent of Andrographis paniculata Nees; a preliminary communication Ind Med Gaz 86 1951 96 97
36. D. Champagne, D. Pearson, D. Dea, J. Rochford, and J. Poirier The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: implications for Alzheimer's disease Neuroscience 121 2003 99 110
37. V. Chandra, R. Pandav, H.H. Dodge, J.M. Johnston, S.H. Belle, S.T. DeKosky, and et al. Incidence of Alzheimer's disease in a rural community in India: the Indo-US study Neurology 57 2001 985 989
38. J. Chang, A. Rimando, M. Pallas, A. Camins, D. Porquet, J. Reeves, and et al. Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease Neurobiol Aging 33 2012 2062 2071
39. Q. Chang, and X.L. Wang Effects of chiral 3-n-butylphthalide on apoptosis induced by transient focal cerebral ischemia in rats Acta Pharmacol Sin 24 2003 796 804
40. X. Chao, J. Zhou, T. Chen, W. Liu, W. Dong, Y. Qu, and et al. Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats Brain Res 1363 2010 206 211
41. S.Y. Chen, Y. Chen, Y.P. Li, S.H. Chen, J.H. Tan, T.M. Ou, and et al. Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease Bioorg Med Chem 19 2011 5596 5604
42. C.Y. Chen, J.H. Jang, M.H. Li, and Y.J. Surh Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells Biochem Biophys Res Commun 331 2005 993 1000
43. Z. Chen, X. Mao, A. Liu, X. Gao, X. Chen, M. Ye, and et al. Osthole, a natural coumarin improves cognitive impairments and BBB dysfunction after transient global brain ischemia in C57 BL/6J mice: involvement of Nrf2 pathway Neurochem Res 40 2015 186 194
44. P.C. Chen, M.R. Vargas, A.K. Pani, R.J. Smeyne, D.A. Johnson, Y.W. Kan, and et al. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte Proc Natl Acad Sci U S A 106 2009 2933 2938
45. C. Cheret, A. Gervais, A. Lelli, C. Colin, L. Amar, P. Ravassard, and et al. Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase J Neurosci 28 2008 12039 12051
46. S.J. Chinta, J.K. Mallajosyula, A. Rane, and J.K. Andersen Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo Neurosci Lett 486 2010 235 239
47. Y.C. Cho, S.H. Lee, G. Yoon, H.S. Kim, J.Y. Na, H.J. Choi, and et al. Licochalcone E reduces chronic allergic contact dermatitis and inhibits IL-12p40 production through down-regulation of NF-kappa B Int Immunopharmacol 10 2010 1119 1126
48. Y.B. Choi, Y.I. Kim, K.S. Lee, B.S. Kim, and D.J. Kim Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats Brain Res 1019 2004 47 54
49. S. Chowdhry, Y. Zhang, M. McMahon, C. Sutherland, A. Cuadrado, and J.D. Hayes Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity Oncogene 32 2013 3765 3781
50. C.M. Clements, R.S. McNally, B.J. Conti, T.W. Mak, and J.P. Ting DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2 Proc Natl Acad Sci U S A 103 2006 15091 15096
51. D. Colle, J.M. Hartwig, F.A. Soares, and M. Farina Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro Brain Res Bull 87 2012 397 405
52. D. Colle, D.B. Santos, J.M. Hartwig, M. Godoi, A.L. Braga, and M. Farina Succinobucol versus probucol: higher efficiency of succinobucol in mitigating 3-NP-induced brain mitochondrial dysfunction and oxidative stress in vitro Mitochondrion 13 2013 125 133
53. D. Colle, D.B. Santos, J.M. Hartwig, M. Godoi, D.F. Engel, A.F. de Bem, and et al. Succinobucol, a lipid-lowering drug, protects against 3-nitropropionic acid-induced mitochondrial dysfunction and oxidative stress in SH-SY5Y cells via upregulation of glutathione levels and glutamate cysteine ligase activity Mol Neurobiol http://dx.
54. A. Contestabile Amyotrophic lateral sclerosis: from research to therapeutic attempts and therapeutic perspectives Curr Med Chem 18 2011 5655 5665
55. M.R. Cookson DJ-1, PINK1, and their effects on mitochondrial pathways Mov Disord 25 Suppl. 1 2010 S44 S48
56. J. Cooper R. Barchi, L. Kunk, Glutathione in the Brain: Disorders of Glutathione Metabolism 1997
57. A. Cuadrado, and A.I. Rojo Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections Curr Pharm Des 14 2008 429 442
58. L.Y. Cui, Y.C. Zhu, S. Gao, J.M. Wang, B. Peng, J. Ni, and et al. Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: a randomized, double-blind trial Chin Med J (Engl) 126 2013 3405 3410
59. F. Darios, O. Corti, C.B. Lucking, C. Hampe, M.P. Muriel, N. Abbas, and et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death Hum Mol Genet 12 2003 517 526
60. K. Dasuri, L. Zhang, and J.N. Keller Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis Free Radic Biol Med 62 2013 170 185
61. S. Davinelli, N. Sapere, D. Zella, R. Bracale, M. Intrieri, and G. Scapagnini Pleiotropic protective effects of phytochemicals in Alzheimer's disease Oxid Med Cell Longev 2012 2012 386527
62. R. de Jong, A.C. Bezemer, T.P. Zomerdijk, T. van de Pouw-Kraan, T.H. Ottenhoff, and P.H. Nibbering Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate Eur J Immunol 26 1996 2067 2074
63. L.M. de Lau, and M.M. Breteler Epidemiology of Parkinson's disease Lancet Neurol 5 2006 525 535
64. D. de Zeeuw, T. Akizawa, P. Audhya, G.L. Bakris, M. Chin, H. Christ-Schmidt, and et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease N Engl J Med 369 2013 2492 2503
65. S.T. DeKosky, J.D. Williamson, A.L. Fitzpatrick, R.A. Kronmal, D.G. Ives, J.A. Saxton, and et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial JAMA 300 2008 2253 2262
66. S. Dhakshinamoorthy, and A.K. Jaiswal Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene Oncogene 20 2001 3906 3917
67. Y. Ding, M. Chen, M. Wang, Y. Li, and A. Wen Posttreatment with 11-keto-beta-boswellic acid ameliorates cerebral ischemia-reperfusion injury: Nrf2/HO-1 pathway as a potential mechanism Mol Neurobiol 52 2015 1430 1439
68. R. Domitrovic, M. Skoda, V. Vasiljev Marchesi, O. Cvijanovic, E. Pernjak Pugel, and M.B. Stefan Rosmarinic acid ameliorates acute liver damage and fibrogenesis in carbon tetrachloride-intoxicated mice Food Chem Toxicol 51 2013 370 378
69. L.L. Du, J.Z. Xie, X.S. Cheng, X.H. Li, F.L. Kong, X. Jiang, and et al. Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin-induced tau hyperphosphorylation and cognitive injuries in rat hippocampi Age (Dordr) 36 2014 613 623
70. M. Dumont, E. Wille, N.Y. Calingasan, D. Tampellini, C. Williams, G.K. Gouras, and et al. Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease J Neurochem 109 2009 502 512
71. J. Egea, I. Buendia, E. Parada, E. Navarro, P. Rada, A. Cuadrado, and et al. Melatonin-sulforaphane hybrid ITH12674 induces neuroprotection in oxidative stress conditions by a 'drug-prodrug' mechanism of action Br J Pharmacol 172 2015 1807 1821
72. J. Egea, A.O. Rosa, S. Lorrio, L. del Barrio, A. Cuadrado, and M.G. Lopez Haeme oxygenase-1 overexpression via nAChRs and the transcription factor Nrf2 has antinociceptive effects in the formalin test Pain 146 2009 75 83
73. J. Egea, A.O. Rosa, M. Sobrado, L. Gandia, M.G. Lopez, and A.G. Garcia Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in alpha7 nicotinic receptor knockout mice Neuroscience 145 2007 866 872
74. G. Ellrichmann, E. Petrasch-Parwez, D.H. Lee, C. Reick, L. Arning, C. Saft, and et al. Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease PLoS One 6 2011 e16172
75. S.M. Elshazly, D.M. Abd El Motteleb, and N.N. Nassar The selective 5-LOX inhibitor 11-keto-beta-boswellic acid protects against myocardial ischemia reperfusion injury in rats: involvement of redox and inflammatory cascades Naunyn Schmiedebergs Arch Pharmacol 386 2013 823 833
76. X. Feng, N. Liang, D. Zhu, Q. Gao, L. Peng, H. Dong, and et al. Resveratrol inhibits beta-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathway PLoS One 8 2013 e59888
77. X. Feng, Y. Peng, M. Liu, and L. Cui dl-3-n-Butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis Neuropharmacology 62 2012 1004 1010
78. S.M. Fereshtehnejad, and J. Lokk Active aging for individuals with Parkinson's disease: definitions, literature review, and models Park Dis 2014 2014 739718
79. H.H. Fernandez Updates in the medical management of Parkinson disease Cleve Clin J Med 79 2012 28 35
80. R.J. Ferrante, L.A. Shinobu, J.B. Schulz, R.T. Matthews, C.E. Thomas, N.W. Kowall, and et al. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation Ann Neurol 42 1997 326 334
81. D.C. Fitzgerald, G.X. Zhang, M. El-Behi, Z. Fonseca-Kelly, H. Li, S. Yu, and et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells Nat Immunol 8 2007 1372 1379
82. P. Foley, M. Gerlach, K.L. Double, and P. Riederer Dopamine receptor agonists in the therapy of Parkinson's disease J Neural Transm 111 2004 1375 1446
83. L.B. Fontes, D. Dos Santos Dias, L.S. de Carvalho, H.L. Mesquita, L. da Silva Reis, A.T. Dias, and et al. Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis J Pharm Pharmacol 66 2014 886 894
84. R.J. Fox, D.H. Miller, J.T. Phillips, M. Hutchinson, E. Havrdova, M. Kita, and et al. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis N Engl J Med 367 2012 1087 1097
85. S.A. Frautschy, W. Hu, P. Kim, S.A. Miller, T. Chu, M.E. Harris-White, and et al. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology Neurobiol Aging 22 2001 993 1005
86. C.J. Frijns, and L.J. Kappelle Inflammatory cell adhesion molecules in ischemic cerebrovascular disease Stroke 33 2002 2115 2122
87. E.M. Frohman, M.K. Racke, and C.S. Raine Multiple sclerosis - the plaque and its pathogenesis N Engl J Med 354 2006 942 955
88. J. Furusawa, M. Funakoshi-Tago, K. Tago, T. Mashino, H. Inoue, Y. Sonoda, and et al. Licochalcone A significantly suppresses LPS signaling pathway through the inhibition of NF-kappaB p65 phosphorylation at serine 276 Cell Signal 21 2009 778 785
89. L. Gan, and J.A. Johnson Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases Biochim Biophys Acta 1842 2014 1208 1218
90. X. Gao, A. Cassidy, M.A. Schwarzschild, E.B. Rimm, and A. Ascherio Habitual intake of dietary flavonoids and risk of Parkinson disease Neurology 78 2012 1138 1145
91. S. Gao, X. Duan, X. Wang, D. Dong, D. Liu, X. Li, and et al. Curcumin attenuates arsenic-induced hepatic injuries and oxidative stress in experimental mice through activation of Nrf2 pathway, promotion of arsenic methylation and urinary excretion Food Chem Toxicol 59 2013 739 747
92. Y. Gilgun-Sherki, E. Melamed, and D. Offen Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier Neuropharmacology 40 2001 959 975
93. R. Gold, L. Kappos, D.L. Arnold, A. Bar-Or, G. Giovannoni, K. Selmaj, and et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis N Engl J Med 367 2012 1098 1107
94. C.A. Goodall, M.W. Head, D. Everington, J.W. Ironside, R.S. Knight, and A.J. Green Raised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications J Neurol Neurosurg Psychiatry 77 2006 89 91
95. E.F. Goodall, and K.E. Morrison Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment Expert Rev Mol Med 8 2006 1 22
96. Z. Gu, T. Nakamura, D. Yao, Z.Q. Shi, and S.A. Lipton Nitrosative and oxidative stress links dysfunctional ubiquitination to Parkinson's disease Cell Death Differ 12 2005 1202 1204
97. M.E. Gurney, H. Pu, A.Y. Chiu, M.C. Dal Canto, C.Y. Polchow, D.D. Alexander, and et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation Science 264 1994 1772 1775
98. L. Haider, M.T. Fischer, J.M. Frischer, J. Bauer, R. Hoftberger, G. Botond, and et al. Oxidative damage in multiple sclerosis lesions Brain 134 2011 1914 1924
99. B. Halliwell Proteasomal dysfunction: a common feature of neurodegenerative diseases? Implications for the environmental origins of neurodegeneration Antioxid Redox Signal 8 2006 2007 2019
100. J. Han, M. Wang, X. Jing, H. Shi, M. Ren, and H. Lou (-)-Epigallocatechin gallate protects against cerebral ischemia-induced oxidative stress via Nrf2/ARE signaling Neurochem Res 39 2014 1292 1299
101. S. Hands, M.U. Sajjad, M.J. Newton, and A. Wyttenbach In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production J Biol Chem 286 2011 44512 44520
102. H. Haraguchi, H. Ishikawa, K. Mizutani, Y. Tamura, and T. Kinoshita Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata Bioorg Med Chem 6 1998 339 347
103. H.J. Heo, D.O. Kim, S.C. Shin, M.J. Kim, B.G. Kim, and D.H. Shin Effect of antioxidant flavanone, naringenin, from Citrus junoson neuroprotection J Agric Food Chem 52 2004 1520 1525
104. M. Hirotani, C. Maita, M. Niino, S. Iguchi-Ariga, S. Hamada, H. Ariga, and et al. Correlation between DJ-1 levels in the cerebrospinal fluid and the progression of disabilities in multiple sclerosis patients Mult Scler 14 2008 1056 1060
105. D.W. Holman, R.S. Klein, and R.M. Ransohoff The blood-brain barrier, chemokines and multiple sclerosis Biochim Biophys Acta 1812 2011 220 230
106. K.G. Hooten, D.R. Beers, W. Zhao, and S.H. Appel Protective and toxic neuroinflammation in amyotrophic lateral sclerosis Neurotherapeutics 12 2015 364 375
107. T.C. Hsieh, X. Lu, Z. Wang, and J.M. Wu Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2 Med Chem 2 2006 275 285
108. Y. Hu, M. Duan, S. Liang, Y. Wang, and Y. Feng Senkyunolide I protects rat brain against focal cerebral ischemia-reperfusion injury by up-regulating p-Erk1/2, Nrf2/HO-1 and inhibiting caspase 3 Brain Res 1605 2015 39 48
109. Q. Hu, D.D. Zhang, L. Wang, H. Lou, and D. Ren Eriodictyol-7-O-glucoside, a novel Nrf2 activator, confers protection against cisplatin-induced toxicity Food Chem Toxicol 50 2012 1927 1932
110. J.Z. Huang, Y.Z. Chen, M. Su, H.F. Zheng, Y.P. Yang, J. Chen, and et al. dl-3-n-Butylphthalide prevents oxidative damage and reduces mitochondrial dysfunction in an MPP(+)-induced cellular model of Parkinson's disease Neurosci Lett 475 2010 89 94
111. H.C. Huang, T. Nguyen, and C.B. Pickett Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2 Proc Natl Acad Sci U S A 97 2000 12475 12480
112. R. Ihl Effects of Ginkgo biloba extract EGb 761 (R) in dementia with neuropsychiatric features: review of recently completed randomised, controlled trials Int J Psychiatry Clin Pract 17 Suppl. 1 2013 8 14
113. N.G. Innamorato, A. Jazwa, A.I. Rojo, C. Garcia, J. Fernandez-Ruiz, A. Grochot-Przeczek, and et al. Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1 PLoS One 5 2010 e11838
114. N.G. Innamorato, A.I. Rojo, A.J. Garcia-Yague, M. Yamamoto, M.L. de Ceballos, and A. Cuadrado The transcription factor Nrf2 is a therapeutic target against brain inflammation J Immunol 181 2008 680 689
115. N. Izigov, N. Farzam, and N. Savion S-allylmercapto-N-acetylcysteine up-regulates cellular glutathione and protects vascular endothelial cells from oxidative stress Free Radic Biol Med 50 2011 1131 1139
116. K.M. Jacobs, S.R. Bhave, D.J. Ferraro, J.J. Jaboin, D.E. Hallahan, and D. Thotala GSK-3beta: a bifunctional role in cell death pathways Int J Cell Biol 2012 2012 930710
117. F. Jadidi-Niaragh, and A. Mirshafiey Th17 cell, the new player of neuroinflammatory process in multiple sclerosis Scand J Immunol 74 2011 1 13
118. A. Jager, and V.K. Kuchroo Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation Scand J Immunol 72 2010 173 184
119. A.K. Jain, and A.K. Jaiswal GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2 J Biol Chem 282 2007 16502 16510
120. R.J. Jakel, and W.F. Maragos Neuronal cell death in Huntington's disease: a potential role for dopamine Trends Neurosci 23 2000 239 245
121. A.A. Javkhedkar, Y. Quiroz, B. Rodoriguez-Iturbe, N.D. Vaziri, M.F. Lokhandwala, and A.A. Banday Resveratrol restored Nrf2 function, reduced renal inflammation and mitigated hypertension in spontaneously hypertensive rats Am J Physiol Regul Integr Comp Physiol 308 2015 R840-846 (ajpregu 00308 02014)
122. H.J. Ji, J.F. Hu, Y.H. Wang, X.Y. Chen, R. Zhou, and N.H. Chen Osthole improves chronic cerebral hypoperfusion induced cognitive deficits and neuronal damage in hippocampus Eur J Pharmacol 636 2010 96 101
123. N. Jia, K. Han, J.J. Kong, X.M. Zhang, S. Sha, G.R. Ren, and et al. (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus Mol Cell Biochem 380 2013 211 218
124. J. Jia, C. Wei, J. Liang, A. Zhou, X. Zuo, H. Song, and et al. The effects of dl-3-n-butylphthalide in patients with vascular cognitive impairment no dementia caused by subcortical ischemic small vessel disease: a multicentre, randomized, double-blind, placebo-controlled trial Alzheimers Dement 2015 10.1016/j.jalz.2015.04.010 (in press)
125. D. Jiang, L. Men, J. Wang, Y. Zhang, S. Chickenyen, Y. Wang, and et al. Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance Biochemistry 46 2007 9270 9282
126. H. Jiang, X. Tian, Y. Guo, W. Duan, H. Bu, and C. Li Activation of nuclear factor erythroid 2-related factor 2 cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity Biol Pharm Bull 34 2011 1194 1197
127. Y.N. Jin, Y.V. Yu, S. Gundemir, C. Jo, M. Cui, K. Tieu, and et al. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin PLoS One 8 2013 e57932
128. X. Jing, D. Ren, X. Wei, H. Shi, X. Zhang, R.G. Perez, and et al. Eriodictyol-7-O-glucoside activates Nrf2 and protects against cerebral ischemic injury Toxicol Appl Pharmacol 273 2013 672 679
129. D.A. Johnson, S. Amirahmadi, C. Ward, Z. Fabry, and J.A. Johnson The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis Toxicol Sci 114 2010 237 246
130. J.A. Joseph, D.R. Fisher, V. Cheng, A.M. Rimando, and B. Shukitt-Hale Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging J Agric Food Chem 56 2008 10544 10551
131. G. Joshi, and J.A. Johnson The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases Recent Pat CNS Drug Discov 7 2012 218 229
132. K.A. Jung, and M.K. Kwak The Nrf2 system as a potential target for the development of indirect antioxidants Molecules 15 2010 7266 7291
133. B.H. Juurlink, S.K. Thorburne, and L. Hertz Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress Glia 22 1998 371 378
134. N.A. Kaidery, R. Banerjee, L. Yang, N.A. Smirnova, D.M. Hushpulian, K.T. Liby, and et al. Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease Antioxid Redox Signal 18 2013 139 157
135. Q.C. Kan, S. Zhang, Y.M. Xu, G.X. Zhang, and L. Zhu Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis Neurosci Lett 560 2014 92 97
136. Q.C. Kan, L. Zhu, N. Liu, and G.X. Zhang Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity Immunol Res 56 2013 189 196
137. S. Kanakasabai, E. Casalini, C.C. Walline, C. Mo, W. Chearwae, and J.J. Bright Differential regulation of CD4(+) T helper cell responses by curcumin in experimental autoimmune encephalomyelitis J Nutr Biochem 23 2012 1498 1507
138. K. Kanninen, T.M. Malm, H.K. Jyrkkanen, G. Goldsteins, V. Keksa-Goldsteine, H. Tanila, and et al. Nuclear factor erythroid 2-related factor 2 protects against beta amyloid Mol Cell Neurosci 39 2008 302 313
139. T. Kanno, K. Tanaka, Y. Yanagisawa, K. Yasutake, S. Hadano, F. Yoshii, and et al. A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2-ARE pathway: therapeutic implications for ALS Free Radic Biol Med 53 2012 2028 2042
140. T.K. Kao, C.Y. Chang, Y.C. Ou, W.Y. Chen, Y.H. Kuan, H.C. Pan, and et al. Tetramethylpyrazine reduces cellular inflammatory response following permanent focal cerebral ischemia in rats Exp Neurol 247 2013 188 201
141. S. Kapeta, N. Chondrogianni, and E.S. Gonos Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts J Biol Chem 285 2010 8171 8184
142. J.W. Kaspar, and A.K. Jaiswal An autoregulatory loop between Nrf2 and Cul3-Rbx1 controls their cellular abundance J Biol Chem 285 2010 21349 21358
143. Y.S. Keum, S. Yu, P.P. Chang, X. Yuan, J.H. Kim, C. Xu, and et al. Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells Cancer Res 66 2006 8804 8813
144. N. Khan, and M.T. Smith Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models Inflammopharmacology 22 2014 1 22
145. W.D. Kim, Y.W. Kim, I.J. Cho, C.H. Lee, and S.G. Kim E-cadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells J Cell Sci 125 2012 1284 1295
146. H.V. Kim, H.Y. Kim, H.Y. Ehrlich, S.Y. Choi, D.J. Kim, and Y. Kim Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model Amyloid 20 2013 7 12
147. S.S. Kim, J. Lim, Y. Bang, J. Gal, S.U. Lee, Y.C. Cho, and et al. Licochalcone E activates Nrf2/antioxidant response element signaling pathway in both neuronal and microglial cells: therapeutic relevance to neurodegenerative disease J Nutr Biochem 23 2012 1314 1323
148. D. Kim, M.D. Nguyen, M.M. Dobbin, A. Fischer, F. Sananbenesi, J.T. Rodgers, and et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis EMBO J 26 2007 3169 3179
149. T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, S. Minoshima, and et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 1998 605 608
150. K. Kitani, T. Osawa, and T. Yokozawa The effects of tetrahydrocurcumin and green tea polyphenol on the survival of male C57BL/6 mice Biogerontology 8 2007 567 573
151. K. Kobayashi, S. Imagama, T. Ohgomori, K. Hirano, K. Uchimura, K. Sakamoto, and et al. Minocycline selectively inhibits M1 polarization of microglia Cell Death Dis 4 2013 e525
152. A. Kobayashi, M.I. Kang, H. Okawa, M. Ohtsuji, Y. Zenke, T. Chiba, and et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2 Mol Cell Biol 24 2004 7130 7139
153. S.H. Koh, H. Kwon, K.S. Kim, J. Kim, M.H. Kim, H.J. Yu, and et al. Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals Toxicology 202 2004 213 225
154. S.H. Koh, S.M. Lee, H.Y. Kim, K.Y. Lee, Y.J. Lee, H.T. Kim, and et al. The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice Neurosci Lett 395 2006 103 107
155. T. Kondo, T. Ito, and Y. Sugita Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum Ann N Y Acad Sci 738 1994 222 229
156. X. Kuang, V.L. Scofield, M. Yan, G. Stoica, N. Liu, and P.K. Wong Attenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in mice Brain Res 1286 2009 174 184
157. J. Kuhnl, D. Roggenkamp, S.A. Gehrke, F. Stab, H. Wenck, L. Kolbe, and et al. Licochalcone A activates Nrf2 in vitro and contributes to licorice extract-induced lowered cutaneous oxidative stress in vivo Exp Dermatol 24 2015 42 47
158. V.S. Kumar, A. Gopalakrishnan, M. Naziroglu, and G.K. Rajanikant Calcium ion - the key player in cerebral ischemia Curr Med Chem 21 2014 2065 2075
159. P. Kumar, H. Kalonia, and A. Kumar Huntington's disease: pathogenesis to animal models Pharmacol Rep 62 2010 1 14
160. A. Kumar, S. Kumar Singh, V. Kumar, D. Kumar, S. Agarwal, and M.K. Rana Huntington's disease: an update of therapeutic strategies Gene 556 2015 91 97
161. C. Kunsch, J. Luchoomun, J.Y. Grey, L.K. Olliff, L.B. Saint, R.F. Arrendale, and et al. Selective inhibition of endothelial and monocyte redox-sensitive genes by AGI-1067: a novel antioxidant and anti-inflammatory agent J Pharmacol Exp Ther 308 2004 820 829
162. M.K. Kwak, N. Wakabayashi, J.L. Greenlaw, M. Yamamoto, and T.W. Kensler Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway Mol Cell Biol 23 2003 8786 8794
163. A.E. Lang, and A.M. Lozano Parkinson's disease. First of two parts N Engl J Med 339 1998 1044 1053
164. H. Lassmann Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models Exp Neurol 225 2010 2 8
165. H. Lassmann, W. Bruck, and C.F. Lucchinetti The immunopathology of multiple sclerosis: an overview Brain Pathol 17 2007 210 218
166. H. Lassmann, and J. van Horssen The molecular basis of neurodegeneration in multiple sclerosis FEBS Lett 585 2011 3715 3723
167. I. Lastres-Becker, A. Ulusoy, N.G. Innamorato, G. Sahin, A. Rabano, D. Kirik, and et al. alpha-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease Hum Mol Genet 21 2012 3173 3192
168. H. Lee, J.H. Bae, and S.R. Lee Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils J Neurosci Res 77 2004 892 900
169. C. Lee, G.H. Park, S.R. Lee, and J.H. Jang Attenuation of beta-amyloid-induced oxidative cell death by sulforaphane via activation of NF-E2-related factor 2 Oxid Med Cell Longev 2013 2013 313510
170. B. Li, W. Cui, J. Liu, R. Li, Q. Liu, X.H. Xie, and et al. Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice Exp Neurol 250 2013 239 249
171. L. Li, J. Du, Y. Lian, Y. Zhang, X. Li, Y. Liu, and et al. Protective effects of coenzyme Q10 against hydrogen peroxide-induced oxidative stress in PC12 cell: the role of Nrf2 and antioxidant enzymes Cell Mol Neurobiol 2015
172. J. Li, Y. Li, M. Ogle, X. Zhou, M. Song, S.P. Yu, and et al. dl-3-n-Butylphthalide prevents neuronal cell death after focal cerebral ischemia in mice via the JNK pathway Brain Res 1359 2010 216 226
173. L. Li, X. Zhang, L. Cui, L. Wang, H. Liu, H. Ji, and et al. Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice Brain Res 1497 2013 32 39
174. L. Li, B. Zhang, Y. Tao, Y. Wang, H. Wei, J. Zhao, and et al. dl-3-n-Butylphthalide protects endothelial cells against oxidative/nitrosative stress, mitochondrial damage and subsequent cell death after oxygen glucose deprivation in vitro Brain Res 1290 2009 91 101
175. K. Liby, T. Hock, M.M. Yore, N. Suh, A.E. Place, R. Risingsong, and et al. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling Cancer Res 65 2005 4789 4798
176. K.T. Liby, M.M. Yore, and M.B. Sporn Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer Nat Rev Cancer 7 2007 357 369
177. G.P. Lim, T. Chu, F. Yang, W. Beech, S.A. Frautschy, and G.M. Cole The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse J Neurosci 21 2001 8370 8377
178. J.H. Lim, K.M. Kim, S.W. Kim, O. Hwang, and H.J. Choi Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage Pharmacol Res 57 2008 325 331
179. S.H. Lim, H.S. Kim, Y.K. Kim, T.M. Kim, S. Im, M.E. Chung, and et al. The functional effect of epigallocatechin gallate on ischemic stroke in rats Acta Neurobiol Exp (Wars) 70 2010 40 46
180. M.T. Lin, and M.F. Beal Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 2006 787 795
181. S.X. Lin, L. Lisi, C. Dello Russo, P.E. Polak, A. Sharp, G. Weinberg, and et al. The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1 ASN Neuro 3 2011
182. R.A. Linker, D.H. Lee, S. Ryan, A.M. van Dam, R. Conrad, P. Bista, and et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway Brain 134 2011 678 692
183. X.P. Liu, C.E. Goldring, I.M. Copple, H.Y. Wang, W. Wei, N.R. Kitteringham, and et al. Extract of Ginkgo biloba induces phase 2 genes through Keap1-Nrf2-ARE signaling pathway Life Sci 80 2007 1586 1591
184. N. Liu, Q.C. Kan, X.J. Zhang, Y.M. Xv, S. Zhang, G.X. Zhang, and et al. Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis Exp Mol Pathol 97 2014 470 476
185. J. Liu, Q. Wu, Y.F. Lu, and J. Pi New insights into generalized hepatoprotective effects of oleanolic acid: key roles of metallothionein and Nrf2 induction Biochem Pharmacol 76 2008 922 928
186. Y. Liu, L. Zhang, and J. Liang Activation of the Nrf2 defense pathway contributes to neuroprotective effects of phloretin on oxidative stress injury after cerebral ischemia/reperfusion in rats J Neurol Sci 351 2015 88 92
187. E.H. Lo, T. Dalkara, and M.A. Moskowitz Mechanisms, challenges and opportunities in stroke Nat Rev Neurosci 4 2003 399 415
188. H. Lou, X. Jing, X. Wei, H. Shi, D. Ren, and X. Zhang Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway Neuropharmacology 79 2014 380 388
189. A.E. Lovett-Racke, Y. Yang, and M.K. Racke Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochim Biophys Acta 1812 2011 246 251
190. C. Lu, J. Zhang, X. Shi, S. Miao, L. Bi, S. Zhang, and et al. Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson's disease induced by MPTP Int J Biol Sci 10 2014 350 357
191. F. Luchetti, B. Canonico, M. Betti, M. Arcangeletti, F. Pilolli, M. Piroddi, and et al. Melatonin signaling and cell protection function FASEB J 24 2010 3603 3624
192. Y. Luo, J.V. Smith, V. Paramasivam, A. Burdick, K.J. Curry, J.P. Buford, and et al. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761 Proc Natl Acad Sci U S A 99 2002 12197 12202
193. J.Q. Ma, J. Ding, L. Zhang, and C.M. Liu Protective effects of ursolic acid in an experimental model of liver fibrosis through Nrf2/ARE pathway Clin Res Hepatol Gastroenterol 39 2015 188 197
194. S. Magesh, Y. Chen, and L. Hu Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents Med Res Rev 32 2012 687 726
195. D. Mahad, I. Ziabreva, H. Lassmann, and D. Turnbull Mitochondrial defects in acute multiple sclerosis lesions Brain 131 2008 1722 1735
196. D. Martelli, M.J. McKinley, and R.M. McAllen The cholinergic anti-inflammatory pathway: a critical review Auton Neurosci 182 2014 65 69
197. R. Martin, J. Carvalho-Tavares, M. Hernandez, M. Arnes, V. Ruiz-Gutierrez, and M.L. Nieto Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: a potential therapeutic role Biochem Pharmacol 79 2010 198 208
198. J.B. Martin, and J.F. Gusella Huntington's disease. Pathogenesis and management N Engl J Med 315 1986 1267 1276
199. D. Martin, A.I. Rojo, M. Salinas, R. Diaz, G. Gallardo, J. Alam, and et al. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol J Biol Chem 279 2004 8919 8929
200. B.A. McCray, and J.P. Taylor The role of autophagy in age-related neurodegeneration Neurosignals 16 2008 75 84
201. R.J. Mead, A. Higginbottom, S.P. Allen, J. Kirby, E. Bennett, S.C. Barber, and et al. S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis Free Radic Biol Med 61 2013 438 452
202. P. Meng, H. Yoshida, T. Matsumiya, T. Imaizumi, K. Tanji, F. Xing, and et al. Carnosic acid suppresses the production of amyloid-beta 1-42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells Neurosci Res 75 2013 94 102
203. V.P. Menon, and A.R. Sudheer Antioxidant and anti-inflammatory properties of curcumin Adv Exp Med Biol 595 2007 105 125
204. P. Milani, G. Ambrosi, O. Gammoh, F. Blandini, and C. Cereda SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration Oxid Med Cell Longev 2013 2013 836760
205. F. Morroni, A. Tarozzi, G. Sita, C. Bolondi, J.M. Zolezzi Moraga, G. Cantelli-Forti, and et al. Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease Neurotoxicology 36 2013 63 71
206. U. Mrowietz, E. Christophers, and P. Altmeyer Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference Br J Dermatol 141 1999 424 429
207. M. Muftuoglu, B. Elibol, O. Dalmizrak, A. Ercan, G. Kulaksiz, H. Ogus, and et al. Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations Mov Disord 19 2004 544 548
208. W.E. Muller, A. Eckert, C. Kurz, G.P. Eckert, and K. Leuner Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease - therapeutic aspects Mol Neurobiol 41 2010 159 171
209. S. Nair, S.T. Doh, J.Y. Chan, A.N. Kong, and L. Cai Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and carcinogenesis Br J Cancer 99 2008 2070 2082
210. K. Nakaso, H. Yano, Y. Fukuhara, T. Takeshima, K. Wada-Isoe, and K. Nakashima PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells FEBS Lett 546 2003 181 184
211. A. Neymotin, N.Y. Calingasan, E. Wille, N. Naseri, S. Petri, M. Damiano, and et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis Free Radic Biol Med 51 2011 88 96
212. S.K. Niture, A.K. Jain, and A.K. Jaiswal Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance J Cell Sci 122 2009 4452 4464
213. S.K. Niture, J.W. Kaspar, J. Shen, and A.K. Jaiswal Nrf2 signaling and cell survival Toxicol Appl Pharmacol 244 2010 37 42
214. S. Numazawa, M. Ishikawa, A. Yoshida, S. Tanaka, and T. Yoshida Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress Am J Physiol Cell Physiol 285 2003 C334 C342
215. R.L. Nussbaum, and C.E. Ellis Alzheimer's disease and Parkinson's disease N Engl J Med 348 2003 1356 1364
216. N. Ogawa, K. Tanaka, M. Asanuma, M. Kawai, T. Masumizu, M. Kohno, and et al. Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro Brain Res 657 1994 207 213
217. M. Okouchi, O. Ekshyyan, M. Maracine, and T.Y. Aw Neuronal apoptosis in neurodegeneration Antioxid Redox Signal 9 2007 1059 1096
218. C.W. Olanow The pathogenesis of cell death in Parkinson's disease - 2007 Mov Disord 22 Suppl. 17 2007 S335 S342
219. J.M. Olcese, C. Cao, T. Mori, M.B. Mamcarz, A. Maxwell, M.J. Runfeldt, and et al. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease J Pineal Res 47 2009 82 96
220. I. Olmez, and H. Ozyurt Reactive oxygen species and ischemic cerebrovascular disease Neurochem Int 60 2012 208 212
221. K. Ono, K. Hasegawa, H. Naiki, and M. Yamada Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro J Neurosci Res 75 2004 742 750
222. R.A. Orlando, A.M. Gonzales, R.E. Royer, L.M. Deck, and D.L. Vander Jagt A chemical analog of curcumin as an improved inhibitor of amyloid Abeta oligomerization PLoS One 7 2012 e31869
223. A.L. Orr, S. Li, C.E. Wang, H. Li, J. Wang, J. Rong, and et al. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking J Neurosci 28 2008 2783 2792
224. R.W. Orrell, R.J. Lane, and M. Ross A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease Amyotroph Lateral Scler 9 2008 195 211
225. L.E. Otterbein, F.H. Bach, J. Alam, M. Soares, H. Tao Lu, M. Wysk, and et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway Nat Med 6 2000 422 428
226. M. Ozarowski, P.L. Mikolajczak, A. Bogacz, A. Gryszczynska, M. Kujawska, J. Jodynis-Liebert, and et al. Rosmarinus officinalis L. leaf extract improves memory impairment and affects acetylcholinesterase and butyrylcholinesterase activities in rat brain Fitoterapia 91 2013 261 271
227. E. Parada, I. Buendia, R. Leon, P. Negredo, A. Romero, A. Cuadrado, and et al. Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression J Pineal Res 56 2014 204 212
228. T.K. Pareek, A. Belkadi, S. Kesavapany, A. Zaremba, S.L. Loh, L. Bai, and et al. Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis Sci Rep 1 2011 201
229. J.W. Park, J.S. Hong, K.S. Lee, H.Y. Kim, J.J. Lee, and S.R. Lee Green tea polyphenol (-)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia J Nutr Biochem 21 2010 1038 1044
230. J.A. Park, S. Kim, S.Y. Lee, C.S. Kim, and Kim do, K., Kim, S.J., et al. Beneficial effects of carnosic acid on dieldrin-induced dopaminergic neuronal cell death Neuroreport 19 2008 1301 1304
231. N.L. Payne, A. Dantanarayana, G. Sun, L. Moussa, S. Caine, C. McDonald, and et al. Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination Cell Adh Migr 6 2012 179 189
232. M. Pehar, M.R. Vargas, P. Cassina, A.G. Barbeito, J.S. Beckman, and L. Barbeito Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis Neurodegener Dis 2 2005 139 146
233. M. Pehar, M.R. Vargas, K.M. Robinson, P. Cassina, P.J. Diaz-Amarilla, T.M. Hagen, and et al. Mitochondrial superoxide production and nuclear factor erythroid 2-related factor 2 activation in p75 neurotrophin receptor-induced motor neuron apoptosis J Neurosci 27 2007 7777 7785
234. C.X. Peng, J. Hu, D. Liu, X.P. Hong, Y.Y. Wu, L.Q. Zhu, and et al. Disease-modified glycogen synthase kinase-3beta intervention by melatonin arrests the pathology and memory deficits in an Alzheimer's animal model Neurobiol Aging 34 2013 1555 1563
235. Y. Peng, J. Sun, S. Hon, A.N. Nylander, W. Xia, Y. Feng, and et al. l-3-n-Butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease J Neurosci 30 2010 8180 8189
236. Y. Peng, C. Xing, C.A. Lemere, G. Chen, L. Wang, Y. Feng, and et al. l-3-n-Butylphthalide ameliorates beta-amyloid-induced neuronal toxicity in cultured neuronal cells Neurosci Lett 434 2008 224 229
237. Y. Peng, C. Xing, S. Xu, C.A. Lemere, G. Chen, B. Liu, and et al. l-3-n-Butylphthalide improves cognitive impairment induced by intracerebroventricular infusion of amyloid-beta peptide in rats Eur J Pharmacol 621 2009 38 45
238. J. Pi, Y. Bai, J.M. Reece, J. Williams, D. Liu, M.L. Freeman, and et al. Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2 Free Radic Biol Med 42 2007 1797 1806
239. M.P. Valdecantos, P.L. Prieto-Hontoria, V. Pardo, T. Modol, B. Santamaria, M. Weber, and et al. Essential role of NRF2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes Free Radic Biol Med 84 2015 263 278
240. E. Pollari, G. Goldsteins, G. Bart, J. Koistinaho, and R. Giniatullin The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis Front Cell Neurosci 8 2014 131
241. D. Porquet, G. Casadesus, S. Bayod, A. Vicente, A.M. Canudas, J. Vilaplana, and et al. Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8 Age (Dordr) 35 2013 1851 1865
242. H. Pradeep, J.B. Diya, S. Shashikumar, and G.K. Rajanikant Oxidative stress - assassin behind the ischemic stroke Folia Neuropathol 50 2012 219 230
243. H. Qi, S.O. Siu, Y. Chen, Y. Han, I.K. Chu, Y. Tong, and et al. Senkyunolides reduce hydrogen peroxide-induced oxidative damage in human liver HepG2 cells via induction of heme oxygenase-1 Chem Biol Interact 183 2010 380 389
244. K. Radad, G. Gille, and W.D. Rausch Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease Pharmacol Rep 57 2005 701 712
245. K.A. Radermacher, K. Wingler, F. Langhauser, S. Altenhofer, P. Kleikers, J.J. Hermans, and et al. Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress Antioxid Redox Signal 18 2013 1418 1427
246. C.P. Ramsey, C.A. Glass, M.B. Montgomery, K.A. Lindl, G.P. Ritson, L.A. Chia, and et al. Expression of Nrf2 in neurodegenerative diseases J Neuropathol Exp Neurol 66 2007 75 85
247. H. Rasoolijazi, N. Azad, M.T. Joghataei, M. Kerdari, F. Nikbakht, and M. Soleimani The protective role of carnosic acid against beta-amyloid toxicity in rats Scientific World Journal 2013 2013 917082
248. J.M. Reynolds, G.J. Martinez, Y. Chung, and C. Dong Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation Proc Natl Acad Sci U S A 109 2012 13064 13069
249. K. Rezai-Zadeh, G.W. Arendash, H. Hou, F. Fernandez, M. Jensen, M. Runfeldt, and et al. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice Brain Res 1214 2008 177 187
250. K. Rezai-Zadeh, D. Shytle, N. Sun, T. Mori, H. Hou, D. Jeanniton, and et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice J Neurosci 25 2005 8807 8814
251. R.P. Ribeiro, E.L. Moreira, D.B. Santos, D. Colle, A.A. Dos Santos, K.C. Peres, and et al. Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease Neurochem Res 38 2013 660 668
252. M. Ribeiro, T.R. Rosenstock, A.M. Oliveira, C.R. Oliveira, and A.C. Rego Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells Free Radic Biol Med 74 2014 129 144
253. B.J. Riis, J. Jensen, and C. Christiansen Cyproterone acetate, an alternative gestagen in postmenopausal oestrogen/gestagen therapy Clin Endocrinol (Oxf) 26 1987 327 334
254. J.M. Ringman, S.A. Frautschy, G.M. Cole, D.L. Masterman, and J.L. Cummings A potential role of the curry spice curcumin in Alzheimer's disease Curr Alzheimer Res 2 2005 131 136
255. R. Rodrigo, R. Fernandez-Gajardo, R. Gutierrez, J.M. Matamala, R. Carrasco, A. Miranda-Merchak, and et al. Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities CNS Neurol Disord Drug Targets 12 2013 698 714
256. A.I. Rojo, M.R. Sagarra, and A. Cuadrado GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress J Neurochem 105 2008 192 202
257. D.R. Rosen, T. Siddique, D. Patterson, D.A. Figlewicz, P. Sapp, A. Hentati, and et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 362 1993 59 62
258. C.A. Ross, and M.A. Poirier Opinion: what is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol 6 2005 891 898
259. L.P. Rowland, and N.A. Shneider Amyotrophic lateral sclerosis N Engl J Med 344 2001 1688 1700
260. T.H. Rushmore, R.G. King, K.E. Paulson, and C.B. Pickett Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds Proc Natl Acad Sci U S A 87 1990 3826 3830
261. K. Sahin, C. Orhan, Z. Tuzcu, M. Tuzcu, and N. Sahin Curcumin ameloriates heat stress via inhibition of oxidative stress and modulation of Nrf2/HO-1 pathway in quail Food Chem Toxicol 50 2012 4035 4041
262. M. Salazar, A.I. Rojo, D. Velasco, R.M. de Sagarra, and A. Cuadrado Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2 J Biol Chem 281 2006 14841 14851
263. K.E. Sandoval, and K.A. Witt Blood-brain barrier tight junction permeability and ischemic stroke Neurobiol Dis 32 2008 200 219
264. A. Sarlette, K. Krampfl, C. Grothe, N. Neuhoff, R. Dengler, and S. Petri Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis J Neuropathol Exp Neurol 67 2008 1055 1062
265. T. Satoh, K. Kosaka, K. Itoh, A. Kobayashi, M. Yamamoto, Y. Shimojo, and et al. Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1 J Neurochem 104 2008 1116 1131
266. T. Satoh, S.R. McKercher, and S.A. Lipton Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs Free Radic Biol Med 65 2013 645 657
267. E. Savaskan, G. Olivieri, F. Meier, E. Seifritz, A. Wirz-Justice, and F. Muller-Spahn Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity Gerontology 49 2003 380 383
268. N. Savion, N. Izigov, M. Morein, S. Pri-Chen, and S. Kotev-Emeth S-Allylmercapto-N-acetylcysteine (ASSNAC) protects cultured nerve cells from oxidative stress and attenuates experimental autoimmune encephalomyelitis Neurosci Lett 583 2014 108 113
269. A.H. Schapira Mitochondria in the aetiology and pathogenesis of Parkinson's disease Lancet Neurol 7 2008 97 109
270. A.H. Schapira, C.W. Olanow, J.T. Greenamyre, and E. Bezard Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives Lancet 384 2014 545 555
271. S. Schilling, S. Goelz, R. Linker, F. Luehder, and R. Gold Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration Clin Exp Immunol 145 2006 101 107
272. S. Schimrigk, N. Brune, K. Hellwig, C. Lukas, B. Bellenberg, M. Rieks, and et al. Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study Eur J Neurol 13 2006 604 610
273. H.M. Schipper Heme oxygenase expression in human central nervous system disorders Free Radic Biol Med 37 2004 1995 2011
274. H.M. Schipper, D.A. Bennett, A. Liberman, J.L. Bienias, J.A. Schneider, J. Kelly, and et al. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment Neurobiol Aging 27 2006 252 261
275. J.L. Schwartz, M.D. Creinin, H.C. Pymar, and L. Reid Predicting risk of ovulation in new start oral contraceptive users Obstet Gynecol 99 2002 177 182
276. S.S. Shaftel, W.S. Griffin, and M.K. O'Banion The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective J Neuroinflammation 5 2008 7
277. Z.A. Shah, R.C. Li, A.S. Ahmad, T.W. Kensler, M. Yamamoto, S. Biswal, and et al. The flavanol (-)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway J Cereb Blood Flow Metab 30 2010 1951 1961
278. Y. Shimojo, K. Kosaka, Y. Noda, T. Shimizu, and T. Shirasawa Effect of rosmarinic acid in motor dysfunction and life span in a mouse model of familial amyotrophic lateral sclerosis J Neurosci Res 88 2010 896 904
279. K.J. Smith, R. Kapoor, and P.A. Felts Demyelination: the role of reactive oxygen and nitrogen species Brain Pathol 9 1999 69 92
280. Sporn, M., Liby, K., Gribble, G., Honda, T., & Letterio, J. (2008). Novel amide derivatives of CDDO and methods of use thereof. In R. P. I. U. + (Ed.), WIPO.
281. N. Sriram, S. Kalayarasan, and G. Sudhandiran Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling Pulm Pharmacol Ther 22 2009 221 236
282. C. Stack, D. Ho, E. Wille, N.Y. Calingasan, C. Williams, K. Liby, and et al. Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease Free Radic Biol Med 49 2010 147 158
283. Z. Sun, Z. Huang, and D.D. Zhang Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response PLoS One 4 2009 e6588
284. S.J. Tabrizi, M.W. Cleeter, J. Xuereb, J.W. Taanman, J.M. Cooper, and A.H. Schapira Biochemical abnormalities and excitotoxicity in Huntington's disease brain Ann Neurol 45 1999 25 32
285. H. Takashima, M. Tsujihata, M. Kishikawa, and W.J. Freed Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors Exp Neurol 159 1999 98 104
286. K. Tanaka, T. Kanno, Y. Yanagisawa, K. Yasutake, S. Inoue, N. Hirayama, and et al. A novel acylaminoimidazole derivative, WN1316, alleviates disease progression via suppression of glial inflammation in ALS mouse model PLoS One 9 2014 e87728
287. A. Tarozzi, C. Angeloni, M. Malaguti, F. Morroni, S. Hrelia, and P. Hrelia Sulforaphane as a potential protective phytochemical against neurodegenerative diseases Oxid Med Cell Longev 2013 2013 415078
288. R.K. Thimmulappa, K.H. Mai, S. Srisuma, T.W. Kensler, M. Yamamoto, and S. Biswal Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray Cancer Res 62 2002 5196 5203
289. K.I. Tong, A. Kobayashi, F. Katsuoka, and M. Yamamoto Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism Biol Chem 387 2006 1311 1320
290. A.H. Tsang, and K.K. Chung Oxidative and nitrosative stress in Parkinson's disease Biochim Biophys Acta 1792 2009 643 650
291. K.U. Tufekci, E. Civi Bayin, S. Genc, and K. Genc The Nrf2/ARE pathway: a promising target to counteract mitochondrial dysfunction in Parkinson's disease Park Dis 2011 2011 314082
292. B. Uttara, A.V. Singh, P. Zamboni, and R.T. Mahajan Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options Curr Neuropharmacol 7 2009 65 74
293. M. Valko, D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, and J. Telser Free radicals and antioxidants in normal physiological functions and human disease Int J Biochem Cell Biol 39 2007 44 84
294. J. van Horssen, J.A. Drexhage, T. Flor, W. Gerritsen, P. van der Valk, and H.E. de Vries Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions Free Radic Biol Med 49 2010 1283 1289
295. J. van Horssen, G. Schreibelt, J. Drexhage, T. Hazes, C.D. Dijkstra, P. van der Valk, and et al. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression Free Radic Biol Med 45 2008 1729 1737
296. J. van Horssen, M.E. Witte, G. Schreibelt, and H.E. de Vries Radical changes in multiple sclerosis pathogenesis Biochim Biophys Acta 1812 2011 141 150
297. F.L. van Muiswinkel, R.A. de Vos, J.G. Bol, G. Andringa, E.N. Jansen Steur, D. Ross, and et al. Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra Neurobiol Aging 25 2004 1253 1262
298. W.M. van Roon-Mom, B.A. Pepers, P.A. t Hoen, C.A. Verwijmeren, J.T. den Dunnen, J.C. Dorsman, and et al. Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease BMC Mol Biol 9 2008 84
299. M.R. Vargas, D.A. Johnson, D.W. Sirkis, A. Messing, and J.A. Johnson Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis J Neurosci 28 2008 13574 13581
300. W. Wang, J. Kang, H. Li, J. Su, J. Wu, Y. Xu, and et al. Regulation of endoplasmic reticulum stress in rat cortex by p62/ZIP through the Keap1-Nrf2-ARE signalling pathway after transient focal cerebral ischaemia Brain Inj 27 2013 924 933
301. Y. Wang, N. Liu, X. Su, G. Zhou, G. Sun, F. Du, and et al. Epigallocatechin-3-gallate attenuates transforming growth factor-beta1 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells Biomed Pharmacother 70 2015 260 267
302. Y. Wang, K. Santa-Cruz, C. DeCarli, and J.A. Johnson NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Alzheimer's disease Neurobiol Aging 21 2000 525 531
303. D. Wang, Y. Wang, X. Wan, C.S. Yang, and J. Zhang Green tea polyphenol (-)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway Toxicol Appl Pharmacol 283 2015 65 74
304. S.J. Wang, K.Y. Wang, and W.C. Wang Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes) Neuroscience 125 2004 191 201
305. H. Wilms, J. Sievers, U. Rickert, M. Rostami-Yazdi, U. Mrowietz, and R. Lucius Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation J Neuroinflammation 7 2010 30
306. M.E. Witte, L. Bo, R.J. Rodenburg, J.A. Belien, R. Musters, T. Hazes, and et al. Enhanced number and activity of mitochondria in multiple sclerosis lesions J Pathol 219 2009 193 204
307. M.E. Witte, J.J. Geurts, H.E. de Vries, P. van der Valk, and J. van Horssen Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion 10 2010 411 418
308. S.Y. Woo, J.H. Kim, M.K. Moon, S.H. Han, S.K. Yeon, J.W. Choi, and et al. Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson's disease therapy J Med Chem 57 2014 1473 1487
309. J.R. Woodgett Regulation and functions of the glycogen synthase kinase-3 subfamily Semin Cancer Biol 5 1994 269 275
310. B. Wootla, M. Eriguchi, and M. Rodriguez Is multiple sclerosis an autoimmune disease? Autoimmun Dis 2012 2012 969657
311. G.F. Wu, and E. Alvarez The immunopathophysiology of multiple sclerosis Neurol Clin 29 2011 257 278
312. C.R. Wu, C.W. Tsai, S.W. Chang, C.Y. Lin, L.C. Huang, and C.W. Tsai Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction Chem Biol Interact 225 2015 40 46
313. L. Xie, X.K. Li, N. Funeshima-Fuji, H. Kimura, Y. Matsumoto, Y. Isaka, and et al. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production Int Immunopharmacol 9 2009 575 581
314. Z. Xu, S. Chen, X. Li, G. Luo, L. Li, and W. Le Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis Neurochem Res 31 2006 1263 1269
315. Z. Xu, F. Zhang, F. Sun, K. Gu, S. Dong, and D. He Dimethyl fumarate for multiple sclerosis Cochrane Database Syst Rev 4 2015 CD011076
316. T.A. Yacoubian, and D.G. Standaert Targets for neuroprotection in Parkinson's disease Biochim Biophys Acta 1792 2009 676 687
317. S. Yamashita, and Y. Matsuzawa Where are we with probucol: a new life for an old drug? Atherosclerosis 207 2009 16 23
318. H. Yamazaki, K. Tanji, K. Wakabayashi, S. Matsuura, and K. Itoh Role of the Keap1/Nrf2 pathway in neurodegenerative diseases Pathol Int 65 2015 210 219
319. D. Yanagisawa, N.F. Ibrahim, H. Taguchi, S. Morikawa, K. Hirao, N. Shirai, and et al. Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP/PS1 mice Neurobiol Aging 36 2015 201 210
320. L. Yang, N.Y. Calingasan, B. Thomas, R.K. Chaturvedi, M. Kiaei, E.J. Wille, and et al. Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription PLoS One 4 2009 e5757
321. F. Yang, G.P. Lim, A.N. Begum, O.J. Ubeda, M.R. Simmons, S.S. Ambegaokar, and et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo J Biol Chem 280 2005 5892 5901
322. C. Yang, X. Zhang, H. Fan, and Y. Liu Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia Brain Res 1282 2009 133 141
323. G. Yilmaz, and D.N. Granger Cell adhesion molecules and ischemic stroke Neurol Res 30 2008 783 793
324. G. Yoon, Y.D. Jung, and S.H. Cheon Cytotoxic allyl retrochalcone from the roots of Glycyrrhiza inflata Chem Pharm Bull(Tokyo) 53 2005 694 695
325. H. Yoshida, P. Meng, T. Matsumiya, K. Tanji, R. Hayakari, F. Xing, and et al. Carnosic acid suppresses the production of amyloid-beta 1-42 and 1-43 by inducing an alpha-secretase TACE/ADAM17 in U373MG human astrocytoma cells Neurosci Res 79 2014 83 93
326. M. Yu, H. Li, Q. Liu, F. Liu, L. Tang, C. Li, and et al. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway Cell Signal 23 2011 883 892
327. V. Zbarsky, K.P. Datla, S. Parkar, D.K. Rai, O.I. Aruoma, and D.T. Dexter Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease Free Radic Res 39 2005 1119 1125
328. C. Zeng, P. Zhong, Y. Zhao, K. Kanchana, Y. Zhang, Z.A. Khan, and et al. Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-kappaB both in vitro and in vivo J Mol Cell Cardiol 79 2015 1 12
329. M. Zhang, C. An, Y. Gao, R.K. Leak, J. Chen, and F. Zhang Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection Prog Neurobiol 100 2013 30 47
330. H. Zhang, K.J. Davies, and H.J. Forman Oxidative stress response and Nrf2 signaling in aging Free Radic Biol Med 88 2015 314 336
331. J. Zhang, X. Feng, J. Wu, H. Xu, G. Li, D. Zhu, and et al. Neuroprotective effects of resveratrol on damages of mouse cortical neurons induced by beta-amyloid through activation of SIRT1/Akt1 pathway Biofactors 40 2014 258 267
332. D.D. Zhang, and M. Hannink Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress Mol Cell Biol 23 2003 8137 8151
333. S. Zhang, Q.C. Kan, Y. Xu, G.X. Zhang, and L. Zhu Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis Mediators Inflamm 2013 2013 736085
334. R. Zhang, Q.W. Miao, C.X. Zhu, Y. Zhao, L. Liu, J. Yang, and et al. Sulforaphane ameliorates neurobehavioral deficits and protects the brain from amyloid beta deposits and peroxidation in mice with Alzheimer-like lesions Am J Alzheimers Dis Other Demen 30 2015 183 191
335. Y. Zhang, L. Wang, J. Li, and X.L. Wang 2-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemia J Pharmacol Exp Ther 317 2006 973 979
336. X. Zhao, Q. Kan, L. Zhu, and G.X. Zhang Matrine suppresses production of IL-23/IL-17 and ameliorates experimental autoimmune encephalomyelitis Am J Chin Med 39 2011 933 941
337. J. Zhao, N. Kobori, J. Aronowski, and P.K. Dash Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents Neurosci Lett 393 2006 108 112
338. D. Zielonka, M. Mielcarek, and G.B. Landwehrmeyer Update on Huntington's disease: advances in care and emerging therapeutic options Parkinsonism Relat Disord 21 2015 169 178
339. F. Zipp, and O. Aktas The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases Trends Neurosci 29 2006 518 527